Expression of cytokines and receptors in normal, immortalized, and malignant ovarian epithelial cell lines

Anticancer Research

Volumn 23, Issue 4, 2003, Pages 3151-3157

  Bandera, Christina A ^a   Tsui, Hing Wo ^b   Mok, Samuel C ^a   Tsui, Florence W L ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Cytokine receptors; Cytokines; Immortalized ovarian epithelial cells; Ovarian cancer; Ovarian epithelial cells

Indexed keywords

COLONY STIMULATING FACTOR 1; COLONY STIMULATING FACTOR RECEPTOR; CYTOKINE; CYTOKINE RECEPTOR; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; SOMATOMEDIN B; SOMATOMEDIN C; SOMATOMEDIN RECEPTOR; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR ALPHA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ARTICLE; AUTOCRINE EFFECT; CALORIMETRY; CANCER CELL CULTURE; CANCER INHIBITION; CELL IMMORTALIZATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN CELL; OVARY CARCINOMA; OVARY CELL; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANTIBODIES; CELL DIVISION; CYTOKINES; EPITHELIAL CELLS; FEMALE; HUMANS; OVARIAN NEOPLASMS; OVARY; RECEPTORS, GROWTH FACTOR; TUMOR CELLS, CULTURED;

EID: 0042530221     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Burke F, Relf M, Negus R and Balkwill F: A cytokine profile of normal and malignant ovary. Cytokine 8: 578-585, 1996.
2. Lelber TM and Balkwill FR: Regulation of monocyte MMP-9 production by TNF-alpha and a tumour-derived soluble factor (MMPSF). Br J Cancer 78: 724-732, 1998.
3. Terranova PF and Rice VM: Review: cytokine involvement in ovarian processes. Am J Reprod Immunol 37: 50-63, 1997.
4. Naylor MS, Stamp GW, Foulkes WD, Eccles D and Balkwill FRI: Tumor necrosis factor and its receptors in human ovarian cancer. Potential role in disease progression. J Clin Invest 91: 2194-2206, 1993.
5. Negus RP, Stamp GW, Relf MG, Burke F, Malik ST, Bernasconi S, Allavena P, Sozzani S, Mantovani A and Balkwill FR: The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer. J Clin Invest 95: 2391-2396, 1995.
6. Ness RB and Cottreau C: Possible role of ovarian epithelial inflammation in ovarian cancer. J Natl Cancer Inst 91: 1459-1467,1999
7. Asschert JG, Vellenga E, Hollema H, van der Zee AG and de Vries EG: Expression of macrophage colony-stimulating factor (M-CSF), interleukin-6, (IL-6), interleukin-1 beta (IL-1 beta), interleukin-11 (IL-11) and tumour necrosis factor-alpha (TNF-alpha) in p53-characterised human ovarian carcinomas. Eur J Cancer 33: 2246-2251, 1997.
8. Marth C, Zeimet AG, Herold M, Brumm C, Windbichler G, Muller-Holzner E, Offner F, Feichtinger H, Zwierzina H and Daxenbichler G: Different effects of interferons, interleukin-1beta and tumor necrosis factor-alpha in normal (OSE) and malignant human ovarian epithelial cells. Int J Cancer 67: 826-830, 1996.
9. Goff BA, Shy K, Greer BE, Muntz HG, Skelly M and Gown AM: Overexpression and relationships of HER-2/neu, epidermal growth factor receptor, p53, Ki-67, and tumor necrosis factor alpha in epithelial ovarian cancer. Eur J Gynaecol Oncol 17: 487-492, 1996.
10. Fischer-Colbrie J, Witt A, Heinzl H, Speiser P, Czerwenka K, Sevelda, P and Zeillinger R: EGFR and steroid receptors in ovarian carcinoma: comparison with prognostic parameters and outcome of patients. Anticancer Res 17: 613-619, 1997.
11. Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A et al: Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244: 707-712, 1989.
12. Meden H and Kuhn W: Overexpression of the oncogene c-erbB-2 (HER2/neu) in ovarian cancer: a new prognostic factor. Eur J Obstet Gynecol Reprod Biol 71: 173-179, 1997.
13. Khalifa MA, Lacher DA, Lage JM, Mannel RS, Walker JL, Angros LH and Min KW: Immunohistochemical assessment of proliferation markers and altered gene expression in archival specimens of ovarian epithelial tumors. Cancer Detect Prev 21: 532-539, 1997.
14. Bianco C, Bianco R, Tortora G, Damiano V, Guerrieri P, Montemaggi P, Mendelsohn J, De Placido S, Bianco AR and Ciardiello F: Antitumor activity of combined treatment of human cancer cells with ionizing radiation and anti-epidermal growth factor receptor monoclonal antibody C225 plus type I protein kinase A antisense oligonucleotide. Clin Cancer Res 6: 4343-4350, 2000.
15. Chambers SK, Kacinski BM, Ivins CM and Carcangiu ML: Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-I receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1. Clin Cancer Res 3: 999-1007, 1997.
16. Toy EP, Chambers JT, Kacinski BM, Flick MB and Chambers SK: The activated macrophage colony-stimulating factor (CSF-1) receptor as a predictor of poor outcome in advanced epithelial ovarian carcinoma. Gynecol Oncol 80: 194-200, 2001.
17. Suzuki M, Sekiguchi I, Ohwada M, Sato I, Matsui T, Tanabe T, Hashimoto S and Yamada M: Expression of c-fms proto-oncogene product by ovarian cancer cell lines with effects of macrophage colony-stimulating factor on proliferation. Oncology 53: 99-103, 1996.
18. Tsao SW, Mok SC, Fey EG, Fletcher JA, Wan TS, Chew EC, Muto MG, Knapp RC and Berkowitz RS: Characterization of human ovarian surface epithelial cells immortalized by human papilloma viral oncogenes (HPV-E6E7 ORFs). Exp Cell Res 218: 499-507, 1995.
19. Schummer M, Ng WV, Bumgarner RE, Nelson PS, Schummer B, Bednarski DW, Hassell L, Baldwin RL, Karlan BY and Hood L: Comparative hybridization of an array of 21,500 ovarian cDNAs for the discovery of genes overexpressed in ovarian carcinomas. Gene 238: 375-385, 1999.
20. Saltzman AK, Hartenbach EM, Carter JR, Contreras DN, Twiggs LB, Carson LF and Ramakrishnan S: Transforming growth factor-alpha levels in the serum and ascites of patients with advanced epithelial ovarian cancer. Gynecol Obstet Invest 47: 200-204, 1999.
21. Kurachi H, Adachi H, Morishige K, Adachi K, Takeda T, Homma H, Yamamoto T and Miyake A: Transforming growth factor-alpha promotes tumor markers secretion from human ovarian cancers in vitro. Cancer 78: 1049-1054, 1996.
22. Ueda M, Ueki M, Terai Y, Ueki K, Kumagai K, Fujii H, Yoshizawa K and Nakajima M: Biological implications of growth factors on the mechanism of invasion in gynecological tumor cells. Gynecol Obstet Invest 48: 221-228, 1999.
23. Jayne DG, Perry SL, Morrison E, Farmery SM and Guillou PJ: Activated mesothelial cells produce heparin-binding growth factors: implications for tumour metastases. Br J Cancer 82: 1233-1238, 2000.